1
|
Rico A, Armstrong D, Brady N, León L, Hancock A, Lago A. Selective treatment of clinical mastitis: Assessment of the Net Cash Impact on Dairy Farms Under Diverse Scenarios. A European Perspective. J Dairy Sci 2024:S0022-0302(24)00932-9. [PMID: 38908694 DOI: 10.3168/jds.2023-24341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2023] [Revised: 10/22/2023] [Accepted: 05/28/2024] [Indexed: 06/24/2024]
Abstract
Selective treatment of clinical mastitis (STCM) potentially reduces antimicrobial use without negative implications on cow's milk production or health. However, this approach comes with additional costs. The aim of this study was to evaluate the net cash impact (NCI) of implementing STCM compared with blanket treatment of clinical mastitis (BTCM) under different diagnostic-test turnaround times (24 h, 14 h, and 8 h) using a stochastic partial budget analysis with Monte Carlo simulation. The target population was European commercial dairy herds; therefore, the model inputs were primarily from European sources. Additionally, variables associated with dairy management programs were obtained from USDA sources, worldwide multisite clinical trials, and expert opinion. The output was calculated by subtracting the cost of STCM from the cost of BTCM and it represented the expected NCI if a herd switched from BTCM to STCM. Depending on the time-to-treatment efficiency and diagnostic-test turnaround time, the expected mean NCI, assuming that STCM has no impact on the cow's future health or production, ranged from +€8.7 to +€12.4 per case with 72.4% to 84.8% of the iterations being ≥ €0. Moreover, using the numerically favorable health and production effects of STCM reported in the literature, the expected mean NCI ranged from +€44.5 to +€48.1 per case with 93.6% to 95.4% of the iterations being ≥ €0. The variables with the greatest contribution to NCI variance were proportion of gram-positive cases (39.2% of the variance) and days out of the tank for treated cows (22.0%). However, if future cow's health and production were accounted for, culling risk (24.6%), recurrence risk (19.4%), and milk yield (10.6%) would have the greatest contribution to NCI. The sensitivity analysis indicated that farms with high clinical mastitis incidence, low proportion of gram-positive cases, large number of days out of the tank for treated cows, higher milking frequency or using automatic milking systems, not using the highest priced diagnostic tests, and having high antimicrobial treatment costs are the best candidates for STCM. Improving time-to-treatment efficiency, for example, by using a rapid diagnostic test, leads to a favorable NCI, while high daily milk yield and milk price enhances the NCI in already positive scenarios. Finally, the cash flow entirely depends on future cow's health and milk yield. In conclusion, results indicate that overall, STCM is a practice that positively impacts the NCI of many herds.
Collapse
Affiliation(s)
- A Rico
- DairyExperts Inc., Tulare, CA 93274
| | | | - N Brady
- Zoetis Inc., Parsippany, NJ 07054
| | - L León
- Zoetis Inc., Parsippany, NJ 07054
| | | | - A Lago
- DairyExperts Inc., Tulare, CA 93274.
| |
Collapse
|
2
|
O'Reilly EL, Viora L, Malcata F, Pepler PT, Zadoks R, Brady N, Hanh HQ, McLaughlin M, Horvatic A, Gelemanovic A, Kules J, Mrljak V, Eckersall PD. Biomarker and proteome analysis of milk from dairy cows with clinical mastitis: Determining the effect of different bacterial pathogens on the response to infection. Res Vet Sci 2024; 172:105240. [PMID: 38608347 DOI: 10.1016/j.rvsc.2024.105240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 03/13/2024] [Accepted: 03/23/2024] [Indexed: 04/14/2024]
Abstract
Antimicrobial usage (AMU) could be reduced by differentiating the causative bacteria in cases of clinical mastitis (CM) as either Gram-positive or Gram-negative bacteria or identifying whether the case is culture-negative (no growth, NG) mastitis. Immunoassays for biomarker analysis and a Tandem Mass Tag (TMT) proteomic investigation were employed to identify differences between samples of milk from cows with CM caused by different bacteria. A total of 94 milk samples were collected from cows diagnosed with CM across seven farms in Scotland, categorized by severity as mild (score 1), moderate (score 2), or severe (score 3). Bovine haptoglobin (Hp), milk amyloid A (MAA), C-reactive protein (CRP), lactoferrin (LF), α-lactalbumin (LA) and cathelicidin (CATHL) were significantly higher in milk from cows with CM, regardless of culture results, than in milk from healthy cows (all P-values <0.001). Milk cathelicidin (CATHL) was evaluated using a novel ELISA technique that utilises an antibody to a peptide sequence of SSEANLYRLLELD (aa49-61) common to CATHL 1-7 isoforms. A classification tree was fitted on the six biomarkers to predict Gram-positive bacteria within mastitis severity scores 1 or 2, revealing that compared to the rest of the samples, Gram-positive samples were associated with CRP < 9.5 μg/ml and LF ≥ 325 μg/ml and MAA < 16 μg/ml. Sensitivity of the tree model was 64%, the specificity was 91%, and the overall misclassification rate was 18%. The area under the ROC curve for this tree model was 0.836 (95% bootstrap confidence interval: 0.742; 0.917). TMT proteomic analysis revealed little difference between the groups in protein abundance when the three groups (Gram-positive, Gram-negative and no growth) were compared, however when each group was compared against the entirety of the remaining samples, 28 differentially abundant protein were identified including β-lactoglobulin and ribonuclease. Whilst further research is required to draw together and refine a suitable biomarker panel and diagnostic algorithm for differentiating Gram- positive/negative and NG CM, these results have highlighted a potential panel and diagnostic decision tree. Host-derived milk biomarkers offer significant potential to refine and reduce AMU and circumvent the many challenges associated with microbiological culture, both within the lab and on the farm, while providing the added benefit of reducing turnaround time from 14 to 16 h of microbiological culture to just 15 min with a lateral flow device (LFD).
Collapse
Affiliation(s)
- Emily L O'Reilly
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom; Deanery of Biomedical Sciences, Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, 1 George Square, Edinburgh EH8 9LD, United Kingdom. Emily.O'
| | - Lorenzo Viora
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom.
| | - Francisco Malcata
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom; School of Veterinary Medicine, Oniris, Nantes, France.
| | - P Theo Pepler
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom.
| | - Ruth Zadoks
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom; School of Veterinary Science, University of Sydney, Sydney, Australia.
| | - Nicola Brady
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom.
| | - Han Quang Hanh
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom; Faculty of Animal Science, Vietnam National University of Agriculture, Trau Quy, Gia Lam, Hanoi, Viet Nam.
| | - Mark McLaughlin
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom.
| | - Anita Horvatic
- Faculty of Food Technology and Biotechnology, University of Zagreb, Pierottijeva 6, Zagreb, Croatia; Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10 000 Zagreb, Croatia.
| | - Andrea Gelemanovic
- Mediterranean Institute for Life Sciences (MedILS), 21000 Split, Croatia.
| | - Josipa Kules
- Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10 000 Zagreb, Croatia.
| | - Vladimir Mrljak
- Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10 000 Zagreb, Croatia.
| | - P David Eckersall
- School of Biodiversity, One Health & Veterinary Medicine, University of Glasgow, Bearsden Rd, Glasgow G61 1QH, United Kingdom; Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 10 000 Zagreb, Croatia.
| |
Collapse
|
3
|
Kolar QK, Goncalves JL, Erskine RJ, Ruegg PL. Comparison of Minimum Inhibitory Concentrations of Selected Antimicrobials for Non-Aureus Staphylococci, Enterococci, Lactococci, and Streptococci Isolated from Milk Samples of Cows with Clinical Mastitis. Antibiotics (Basel) 2024; 13:91. [PMID: 38247650 PMCID: PMC10812473 DOI: 10.3390/antibiotics13010091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 12/22/2023] [Accepted: 01/12/2024] [Indexed: 01/23/2024] Open
Abstract
The objective of this study was to compare the minimum inhibitory concentrations of antimicrobials included in a commercial broth microdilution panel among Gram-positive pathogens that caused non-severe clinical mastitis on three Michigan dairy farms. Duplicate quarter milk samples were collected from eligible quarters of cows enrolled in a randomized clinical trial, cultured in a university laboratory, and identified using MALDI-TOF. Etiologies were grouped by genus as Enterococcus species (n = 11), Lactococcus species (n = 44), non-aureus Staphylococcus species (n = 39), or Streptococcus species (n = 25). Minimum inhibitory concentrations (MICs) were determined using the mastitis panel of a commercially available broth microdilution test. In vitro susceptibility was determined using approved guidelines and included breakpoints for mastitis pathogens, or when not available, breakpoints from other species. Most isolates were inhibited at or below breakpoints that demonstrated in vitro susceptibility. The proportions of susceptible isolates varied among pathogens for pirlimycin, penicillin, and tetracycline. The greatest proportion of resistance was observed for pirlimycin, tetracycline, and sulfadimethoxine. Survival analysis was performed to evaluate differences in MICs among pathogen groups. MIC values varied among pathogens for ceftiofur, cephalothin, erythromycin, penicillin, pirlimycin, and tetracycline. However, nearly all isolates were susceptible to ceftiofur and cephalothin, indicating that pathogen differences in MIC are not likely clinically relevant, as these are the two most commonly administered mastitis treatments in the United States. While differences in vitro susceptibility were observed for some antimicrobials, susceptibility was high to cephalosporin-based IMM treatments that are most commonly used and did not vary among pathogens.
Collapse
Affiliation(s)
- Quinn K. Kolar
- Department of Animal Science, Michigan State University, East Lansing, MI 48824, USA;
| | - Juliano L. Goncalves
- Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; (J.L.G.); (R.J.E.)
| | - Ronald J. Erskine
- Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; (J.L.G.); (R.J.E.)
| | - Pamela L. Ruegg
- Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; (J.L.G.); (R.J.E.)
| |
Collapse
|
4
|
Long MM, Needs SH, Edwards AD. Dilution Reduces Sample Matrix Effects for Rapid, Direct, and Miniaturised Phenotypic Antibiotic Susceptibility Tests for Bovine Mastitis. Antibiotics (Basel) 2023; 12:1363. [PMID: 37760660 PMCID: PMC10525283 DOI: 10.3390/antibiotics12091363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Revised: 08/17/2023] [Accepted: 08/19/2023] [Indexed: 09/29/2023] Open
Abstract
The time-consuming nature of current methods for detecting antimicrobial resistance (AMR) to guide mastitis treatment and for surveillance, drives innovation towards faster, easier, and more portable technology. Rapid on-farm testing could guide antibiotic selection, reducing misuse that contributes to resistance. We identify challenges that arise when developing miniaturized antibiotic susceptibility tests (AST) for rapid on-farm use directly in milk. We experimentally studied three factors: sample matrix (specifically milk or spoiled milk); the commensal bacteria found in fresh bovine milk; and result time on the performance of miniaturised AST. Microfluidic "dip-and-test" devices made from microcapillary film (MCF) were able to monitor Gram-negative bacterial growth colourimetrically even in the presence of milk and yoghurt (used to simulate spoiled milk samples), as long as this sample matrix was diluted 1:5 or more in growth medium. Growth detection kinetics using resazurin was not changed by milk at final concentrations of 20% or lower, but a significant delay was seen with yoghurt above 10%. The minimum inhibitory concentration (MIC) for ciprofloxacin and gentamicin was increased in the presence of higher concentrations of milk and yoghurt. When diluted to 1% all observed MIC were within range, indicating dilution may be sufficient to avoid milk matrix interfering with microfluidic AST. We found a median commensal cell count of 6 × 105 CFU/mL across 40 healthy milk samples and tested if these bacteria could alter microfluidic AST. We found that false susceptibility may be observed at early endpoint times if testing some pathogen and commensal mixtures. However, such errors are only expected to occur when a susceptible commensal organism is present at higher cell density relative to the resistant pathogen, and this can be avoided by reading at later endpoints, leading to a trade-off between accuracy and time-to-result. We conclude that with further optimisation, and additional studies of Gram-positive organisms, it should be possible to obtain rapid results for microfluidic AST, but a trade-off is needed between time-to-result, sample dilution, and accuracy.
Collapse
Affiliation(s)
- Matthew Michael Long
- School of Pharmacy, University of Reading, Reading RG6 6DX, UK; (M.M.L.); (S.H.N.)
| | - Sarah Helen Needs
- School of Pharmacy, University of Reading, Reading RG6 6DX, UK; (M.M.L.); (S.H.N.)
| | - Alexander Daniel Edwards
- School of Pharmacy, University of Reading, Reading RG6 6DX, UK; (M.M.L.); (S.H.N.)
- Electronics and Computer Science, University of Southampton, Southampton SO17 1BJ, UK
| |
Collapse
|
5
|
de Jong E, McCubbin KD, Speksnijder D, Dufour S, Middleton JR, Ruegg PL, Lam TJGM, Kelton DF, McDougall S, Godden SM, Lago A, Rajala-Schultz PJ, Orsel K, De Vliegher S, Krömker V, Nobrega DB, Kastelic JP, Barkema HW. Invited review: Selective treatment of clinical mastitis in dairy cattle. J Dairy Sci 2023; 106:3761-3778. [PMID: 37080782 DOI: 10.3168/jds.2022-22826] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Accepted: 01/01/2023] [Indexed: 04/22/2023]
Abstract
Treatment of clinical mastitis (CM) and use of antimicrobials for dry cow therapy are responsible for the majority of animal-defined daily doses of antimicrobial use (AMU) on dairy farms. However, advancements made in the last decade have enabled excluding nonsevere CM cases from antimicrobial treatment that have a high probability of cure without antimicrobials (no bacterial causes or gram-negative, excluding Klebsiella spp.) and cases with a low bacteriological cure rate (chronic cases). These advancements include availability of rapid diagnostic tests and improved udder health management practices, which reduced the incidence and infection pressure of contagious CM pathogens. This review informed an evidence-based protocol for selective CM treatment decisions based on a combination of rapid diagnostic test results, review of somatic cell count and CM records, and elucidated consequences in terms of udder health, AMU, and farm economics. Relatively fast identification of the causative agent is the most important factor in selective CM treatment protocols. Many reported studies did not indicate detrimental udder health consequences (e.g., reduced clinical or bacteriological cures, increased somatic cell count, increased culling rate, or increased recurrence of CM later in lactation) after initiating selective CM treatment protocols using on-farm testing. The magnitude of AMU reduction following a selective CM treatment protocol implementation depended on the causal pathogen distribution and protocol characteristics. Uptake of selective treatment of nonsevere CM cases differs across regions and is dependent on management systems and adoption of udder health programs. No economic losses or animal welfare issues are expected when adopting a selective versus blanket CM treatment protocol. Therefore, selective CM treatment of nonsevere cases can be a practical tool to aid AMU reduction on dairy farms.
Collapse
Affiliation(s)
- Ellen de Jong
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1; One Health at UCalgary, University of Calgary, AB, Canada T2N 4N1; Mastitis Network, Saint-Hyacinthe, QC, Canada J25 2M2
| | - Kayley D McCubbin
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1; One Health at UCalgary, University of Calgary, AB, Canada T2N 4N1; Mastitis Network, Saint-Hyacinthe, QC, Canada J25 2M2
| | - David Speksnijder
- Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; University Animal Health Clinic ULP, 3481 LZ Harmelen, the Netherlands
| | - Simon Dufour
- Mastitis Network, Saint-Hyacinthe, QC, Canada J25 2M2; Department of Pathology and Microbiology, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada J2S 2M2
| | - John R Middleton
- Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia 65211
| | - Pamela L Ruegg
- Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing 48824
| | - Theo J G M Lam
- Department Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; GD Animal Health, 7400 AA Deventer, the Netherlands
| | - David F Kelton
- Mastitis Network, Saint-Hyacinthe, QC, Canada J25 2M2; Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada N1G 2W1
| | - Scott McDougall
- Cognosco, Anexa, Morrinsville 3340, New Zealand; School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand
| | - Sandra M Godden
- Department of Veterinary Population Medicine, University of Minnesota, St. Paul 55108
| | | | - Päivi J Rajala-Schultz
- Department of Production Animal Medicine, Faculty of Veterinary Medicine, 00014 University of Helsinki, Finland
| | - Karin Orsel
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1
| | - Sarne De Vliegher
- M-team and Mastitis and Milk Quality Research Unit, Department of Internal Medicine, Reproduction and Population Health, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium
| | - Volker Krömker
- Section for Animal Production, Nutrition and Health, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark
| | - Diego B Nobrega
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1; One Health at UCalgary, University of Calgary, AB, Canada T2N 4N1
| | - John P Kastelic
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1
| | - Herman W Barkema
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada T2N 4N1; One Health at UCalgary, University of Calgary, AB, Canada T2N 4N1; Mastitis Network, Saint-Hyacinthe, QC, Canada J25 2M2.
| |
Collapse
|
6
|
Zadoks RN, Scholz E, Rowe SM, Norris JM, Pooley HB, House J. A framework for evaluation of on-farm mastitis diagnostics in Australia. Aust Vet J 2023; 101:142-152. [PMID: 36635984 DOI: 10.1111/avj.13228] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2022] [Revised: 12/14/2022] [Accepted: 12/23/2022] [Indexed: 01/14/2023]
Abstract
Numerous culture-based diagnostics are available on the Australian and international markets for on-farm detection of bacterial pathogens in milk. Use of such diagnostics may provide an opportunity to improve the prudent use of antimicrobials in udder health management. Farms are low-resource settings in terms of diagnostic microbiology capacity. The World Health Organisation has identified criteria for the evaluation of diagnostic tests in low resource settings based on Accuracy, Sensitivity, Specificity, User-friendliness, being Rapid or Robust, Equipment-free and being Deliverable (ASSURED). Here, we review how those criteria can be interpreted in the context of microbiological diagnosis of mastitis pathogens, and how on-farm diagnostics that are currently available in Australia perform relative to ASSURED criteria. This evaluation identifies multiple trade-offs, both with regard to scientific criteria and with regards to convenience criteria. More importantly, the purpose of testing may differ between farms, and test performance should be evaluated relative to its intended use. The ability of on-farm mastitis diagnostics to inform mastitis treatment decision-making in a timely and cost-effective manner depends not just on test characteristics but also on farm-specific pathogen prevalence, and on the farm enterprise's priorities and the farm manager's potential courses of action. With most assay evaluations to date conducted in professional laboratories, there is a surprising dearth of information on how well any of the diagnostic tests perform on-farm and, indeed, of the on-farm decision-making processes that they aim to inform.
Collapse
Affiliation(s)
- R N Zadoks
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia
| | - E Scholz
- School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - S M Rowe
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia
| | - J M Norris
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia
| | - H B Pooley
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia
| | - J House
- Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
7
|
Bonestroo J, Fall N, Hogeveen H, Emanuelson U, Klaas IC, van der Voort M. The costs of chronic mastitis: A simulation study of an automatic milking system farm. Prev Vet Med 2023; 210:105799. [PMID: 36436383 DOI: 10.1016/j.prevetmed.2022.105799] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 11/09/2022] [Accepted: 11/12/2022] [Indexed: 11/18/2022]
Abstract
Mastitis is a production disease in dairy farming that causes economic losses. Especially chronic mastitis (i.e., mastitis cases continuing longer than 28 days) can substantially affect the risk of transmission of intramammary infections (IMI) and total milk production losses. Insights into the impact of chronic mastitis on production and farm economics are needed to guide chronic mastitis decision-making. We aimed to estimate the costs of chronic mastitis with a Monte Carlo simulation model in which the costs of chronic mastitis were estimated as part of the total mastitis costs. The model simulated milk yields, IMI dynamics, somatic cell count (SCC), and pregnancy status on an average Dutch dairy farm with 100 cow places over 9 years. The model was parameterized using information from the literature and actual sensor data from automatic milking system (AMS) farms. The daily subclinical milk production losses were modeled using a generalized additive model and sensor data. Transmission of IMI was modeled as well. The model results indicated median total costs of mastitis of € 230 per generic IMI case (i.e., a weighted average of all pathogens). The most substantial cost factors were the extra mastitis cases due to transmission, culling, and milk production losses. Other significant costs originated from dry cow treatments and diverted milk. The model also indicated median total costs due to chronic mastitis of € 118 (51 % of the total mastitis costs). The share of chronic mastitis relative to the total mastitis costs was substantial. Transmission of contagious bacteria had the largest share among the chronic mastitis costs (51 % of the costs of chronic cases). The large share of chronic mastitis costs in the total mastitis costs indicates the economic importance of these mastitis cases. The results of the study point to the need for future research to focus on chronic mastitis and reducing its presence on the AMS dairy farm.
Collapse
Affiliation(s)
- John Bonestroo
- DeLaval International AB, Gustaf De Lavals väg 15, 147 21 Tumba, Sweden; Swedish University of Agricultural Sciences, Dep't Clinical Sciences, POB 7054, SE-750 07 Uppsala, Sweden; Wageningen University and Research, Business Economics Group, Hollandseweg 1, 6706 KN Wageningen, the Netherlands.
| | - Nils Fall
- Swedish University of Agricultural Sciences, Dep't Clinical Sciences, POB 7054, SE-750 07 Uppsala, Sweden
| | - Henk Hogeveen
- Wageningen University and Research, Business Economics Group, Hollandseweg 1, 6706 KN Wageningen, the Netherlands
| | - Ulf Emanuelson
- Swedish University of Agricultural Sciences, Dep't Clinical Sciences, POB 7054, SE-750 07 Uppsala, Sweden
| | | | - Mariska van der Voort
- Wageningen University and Research, Business Economics Group, Hollandseweg 1, 6706 KN Wageningen, the Netherlands
| |
Collapse
|
8
|
Huey S, Kavanagh M, Regan A, Dean M, McKernan C, McCoy F, Ryan EG, Caballero-Villalobos J, McAloon CI. Engaging with selective dry cow therapy: understanding the barriers and facilitators perceived by Irish farmers. Ir Vet J 2021; 74:28. [PMID: 34686221 PMCID: PMC8540178 DOI: 10.1186/s13620-021-00207-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Accepted: 10/12/2021] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Selective dry cow therapy (SDCT) is widely promoted in dairy farming as a method to reduce antimicrobial usage. New legislation introduced by the European Union will restrict and regulate the prophylactic and metaphylactic use of antibiotics from January 2022. Blanket dry cow therapy continues to be a practice engaged in by many farmers in Ireland and for many of these farmers, moving towards SDCT would require a significant infrastructural, behavioural and/or cultural change on their farm. Existing research has reported the important need to understand farmers' motivations to initiate any substantial behaviour change. However, it is currently unknown what farmers know, think and believe about SDCT in Ireland. The aim of this study was to use qualitative methods to explore what barriers and facilitators farmers perceived to exist with SDCT and explore if they had chosen to implement SDCT after voluntarily participating in a funded dry cow consult with a trained veterinarian, with the objective of maximising the dry period udder health performance and moving safely to SDCT. RESULTS In this study, 19 farmers were contacted, and telephone interviews were conducted regarding farmers' beliefs about the consequences of SDCT. Audio recordings were professionally transcribed verbatim and analysed qualitatively using an inductive thematic analysis. The analysis identified 6 barriers and 6 facilitators to implementing SDCT. A significant fear of increasing mastitis incidence was evident that caused reluctance towards SDCT and reliance on antibiotics. Mixed perceptions on SDCT, infrastructure limitations, a perceived lack of preventive advice as well as peer influence were presented as barriers to SDCT. Farmers can build confidence when a graded approach to SDCT is implemented, which could help overcome the fear of SDCT and reliance on antibiotics. Regulatory pressure, high standards of farm hygiene and use of targeted veterinary consults were found to facilitate SDCT. Education was suggested to motivate farmers in the future uptake of SDCT. Despite cited negative influences, peer influence can be utilised to encourage the farming community. CONCLUSIONS This study prioritises areas to facilitate the major behaviour change required as a dairy industry in order to move from blanket dry cow therapy to SDCT.
Collapse
Affiliation(s)
- Sarah Huey
- Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, Northern Ireland
| | - Michaela Kavanagh
- Section of Herd Health and Animal Husbandry, School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Aine Regan
- Agrifood Business and Spatial Analysis, Rural Economy Development Programme, Teagasc Mellows Campus, Athenry, Co. Galway, Ireland
| | - Moira Dean
- Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, Northern Ireland
| | - Clare McKernan
- Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, Northern Ireland
| | - Finola McCoy
- Animal Health Ireland, 4-5 The Archways, Carrick on Shannon, Co. Leitrim, N41 WN27, Ireland
| | - Eoin G Ryan
- Section of Herd Health and Animal Husbandry, School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | | | - Catherine I McAloon
- Section of Herd Health and Animal Husbandry, School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
| |
Collapse
|
9
|
Laboratory-based evaluation of a simplified point-of-care test intended to support treatment decisions in non-severe bovine clinical mastitis. J DAIRY RES 2021; 88:170-175. [PMID: 33958019 DOI: 10.1017/s0022029921000303] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
To limit the use of antimicrobials in dairy cattle, farmers are increasingly encouraged to adopt targeted treatment decisions based on knowledge of the pathogens causing clinical mastitis (CM), whereby treatment of non-severe CM is generally recommended for gram-positive mastitis but not for gram-negative or culture-negative mastitis. The objectives of this study were to conduct a laboratory-based evaluation of the performance of a simplified slide test as a tool to differentiate gram-positive CM from other cases of CM, and to compare its performance against a commercially available on-farm test that is commonly used in our area (VétoRapid). Test outcomes after 24-48 h incubation were compared to results from bacteriological culture and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF MS). Milk samples (n = 156) were obtained from cases of severe and non-severe CM on seven farms and collected by farm personnel. After removal of small numbers of contaminated samples and organisms with unknown species identity, the simplified slide test showed high sensitivity and accuracy (>80%), similar to the comparator test. For most outcomes of interest (culture positive, Escherichia coli, or gram-positive growth), the specificity of the slide test was higher than the specificity of the comparator test. When considering non-severe cases of CM only, and interpreting detection of gram-positive organisms as indicative of the need for antimicrobial treatment, the simplified test had higher specificity (77.4% v. 60.4%) and higher positive predictive value (79.7% v. 70.0%) than the comparator test and similar sensitivity (83.9% v. 87.5%). The proportion of sampled CM cases, contaminated samples and gram-positive mastitis cases - which affects the positive and negative predictive value, the economic value of diagnostic testing and its potential to reduce antimicrobial use - differed between farms. The simplicity and accuracy of the slide test could make it an attractive tool for farmers to target antimicrobial treatment of non-severe clinical mastitis.
Collapse
|
10
|
Griffioen K, Velthuis AGJ, Koop G, Lam TJGM. Effects of a mastitis treatment strategy with or without on-farm testing. J Dairy Sci 2021; 104:4665-4681. [PMID: 33663824 DOI: 10.3168/jds.2019-17871] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Accepted: 08/18/2020] [Indexed: 11/19/2022]
Abstract
The etiology of mastitis is crucial information to use antimicrobials prudently for control and treatment. This study aimed to evaluate the effects of mastitis diagnosis and treatment strategies with on-farm testing, on cure, new intramammary infections (IMI), somatic cell count (SCC), and antimicrobial use, compared with farmers' current diagnosis and treatment strategies. The on-farm tests used, CHROMagar Mastitis (CHROMagar, Paris, France) and Minnesota Easy Culture System II Tri-plate (University of Minnesota, St. Paul, MN), both had etiological groups of IMI as result, being gram-positive growth, gram-negative growth, or culture negative. Two randomized controlled trials were conducted on 15 herds: trial 1 prospectively enrolled 155 cows with clinical mastitis, and trial 2 cross-sectionally included 78 cows with subclinical mastitis. In both trials, cows were randomly distributed over 3 equal-sized groups: a test group using CHROMagar, a test group using Minnesota, and a control group not using on-farm tests. Farmers decided whether or not to treat, and which antimicrobial treatment would be applied, using information available on the day of enrollment (control group), complemented with the on-farm test result 1 d after enrollment (both test groups). For clinical mastitis, an antimicrobial treatment was given in 58% of cases that used CHROMagar, in 80% that used Minnesota, and in 86% of the controls. For subclinical mastitis, an antimicrobial treatment was given in 50% of cases that used CHROMagar, in 54% that used Minnesota, and in 4% of the controls. Bacteriological cure rate of clinical mastitis was lowest in the CHROMagar group [odds ratio 0.18 (95%CI 0.03-0.99)] compared with the controls. Using the Minnesota on-farm test for subclinical mastitis diagnosis and treatments resulted in fewer new IMI on d 21 [odds ratio 0.06 (95%CI 0.00-0.74)] compared with the controls. Clinical cure rate, percentage of new IMI, and SCC on d 21 of clinical mastitis were comparable among the groups. Using on-farm tests in farmers' decision-making process resulted in more treatments in accordance with the etiology of mastitis than without on-farm testing. A diagnosis and treatment strategy with on-farm testing is advised in cows with clinical mastitis to enhance prudent antimicrobial use. For subclinical mastitis, however, on-farm testing may lead to an unacceptable increase in use of antimicrobials and thus should not be advised as the common approach.
Collapse
Affiliation(s)
- Karien Griffioen
- Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.151, 3508 TD, Utrecht, the Netherlands.
| | - Annet G J Velthuis
- Royal GD, PO Box 9, 7400 AA, Deventer, the Netherlands; Aeres University of Applied Sciences, Postbus 374, 8250 AJ, Dronten, the Netherlands
| | - Gerrit Koop
- Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.151, 3508 TD, Utrecht, the Netherlands
| | - Theo J G M Lam
- Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.151, 3508 TD, Utrecht, the Netherlands; Royal GD, PO Box 9, 7400 AA, Deventer, the Netherlands
| | | |
Collapse
|
11
|
Santman-Berends IMGA, van den Heuvel KWH, Lam TJGM, Scherpenzeel CGM, van Schaik G. Monitoring udder health on routinely collected census data: Evaluating the short- to mid-term consequences of implementing selective dry cow treatment. J Dairy Sci 2020; 104:2280-2289. [PMID: 33358166 DOI: 10.3168/jds.2020-18973] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Accepted: 09/25/2020] [Indexed: 11/19/2022]
Abstract
In 2013, the preventive use of antimicrobials in Dutch livestock was prohibited, including a ban on the blanket application of antimicrobial dry cow treatment (BDCT). Since then, selective dry cow treatment (SDCT) has become the standard approach. In this study, we aimed to determine the effect of the ban on BDCT and the extent of the subsequent adoption of SDCT on antimicrobial usage (AMU) and udder health on Dutch dairy farms. In the Dutch cattle health surveillance system, AMU for dry cow treatment (AMUDCT), AMU for intramammary treatment at any point in time (AMUIMM), and udder health indicators are routinely and continuously monitored. This provided the opportunity to study associations among SDCT, udder health, and AMU on census data of approximately 17,000 dairy herds, with about 1.67 million cows in total (>2 yr old) at one moment in time in the period from 2013 until 2017. Six udder health parameters were evaluated using multivariable population-averaged generalized estimating equation models. The year in which the ban on BDCT was introduced (2013) was compared with the period thereafter (2014-2017). Additionally, AMUIMM and AMUDCT were included as independent variables to evaluate whether the extent to which SDCT was implemented on the herd level was associated with udder health. Demographic parameters were included as potential confounders. Since the ban on BDCT, overall declines of 63% in AMUDCT and 15% in AMUIMM were observed. The raw data show an improvement in 5 out of 6 evaluated udder health parameters between 2013 and 2017. Nevertheless, the multivariable model results showed that the period since the ban on BDCT was associated with a small but significant increase in the percentage of cows with high somatic cell count (HSCC) and new HSCC (+0.41% and +0.06%, respectively). Additionally, the probability of belonging to the group of herds with more than 25% of primiparous cows having HSCC during the start of lactation increased slightly, associated with the period after which BDCT was banned (odds ratio = 1.08). The probability of belonging to the group of herds with more than 25% cows having a persistent HSCC during the dry period was not affected and bulk milk somatic cell count showed a slight but significant reduction. The only udder health parameter that notably worsened during the study period was the probability of belonging to the group of herds with more than 25% of multiparous cows with a new HSCC after the dry period, during the start of lactation (odds ratio = 1.23). In herds where the farmer decided not to apply any dry cow therapy (≈20% of all herds), all udder health parameters were poorer compared with herds in which dry cow therapy was applied to some extent. The ban on BDCT and implementation of SDCT in the Netherlands was associated with a considerable reduction in AMU without a major impairment in udder health at the national level. Although negative effects of changed dry cow management were observed in some herds, we conclude that SDCT can be introduced without substantial negative effects on udder health.
Collapse
Affiliation(s)
| | | | - T J G M Lam
- Royal GD, PO Box 9, 7400 AA Deventer, the Netherlands; Department Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, PO Box 80151, 3508 TD Utrecht, the Netherlands
| | | | - G van Schaik
- Royal GD, PO Box 9, 7400 AA Deventer, the Netherlands; Department Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, PO Box 80151, 3508 TD Utrecht, the Netherlands
| |
Collapse
|
12
|
Riveros-Galán DS, Obando-Chaves M. Mastitis, somatic cell count, and its impact on dairy-product quality… An omission in Colombia?: A review. REV COLOMB CIENC PEC 2020. [DOI: 10.17533/udea.rccp.v34n4a01] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Mastitis is the most common disease in dairy herds and the main cause of economic losses in milk production worldwide. This inflammatory reaction of the mammary gland affects the quantity, composition and quality of milk produced and its suitability for the dairy industry. Despite of its importance, Colombia has no regulations on somatic cell count (SCC); that is, no official upper limits have been established for the dairy industry. The current quality-based payment system for raw milk does not encourage local producers to reduce the level of somatic cells. Consequently, Colombia is at a disadvantage compared to countries that include this parameter in their payment schemes and subscribe to international free trade agreements, affecting the competitiveness of the Colombian dairy sector. This article reviews the types of somatic cells, the microbiology of mastitis, its etiology and diagnosis, the changes that generate the composition of milk, and the impact of high SCCs on the quality of dairy products, such as yogurt, cheese, and milk powder. The final section offers a reflection on the problem of high SCCs in Colombia and the lack of regulations in this regard.
Collapse
|
13
|
Chan KW, Bard AM, Adam KE, Rees GM, Morgans L, Cresswell L, Hinchliffe S, Barrett DC, Reyher KK, Buller H. Diagnostics and the challenge of antimicrobial resistance: a survey of UK livestock veterinarians' perceptions and practices. Vet Rec 2020; 187:e125. [PMID: 32948669 DOI: 10.1136/vr.105822] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 06/29/2020] [Accepted: 07/13/2020] [Indexed: 11/04/2022]
Abstract
BACKGROUND This paper explores the current role and place of diagnostic tests in the treatment of farm animal disease. With the growing focus on reduced reliance on antibiotic medicines in both animal and human patient care, attention is increasingly being focused on the practice, the technology and the function of diagnostic tests and how these can support responsible antimicrobial use. Emerging diagnostic technologies offer the possibility of more rapid testing for bacterial disease, while food chain actors and others are increasingly seeking to make diagnostic tests mandatory before the use of critically important antibiotics. METHOD This paper reports the findings of a recent large-scale online survey of UK farm animal veterinarians (n=153) which investigated current veterinary diagnostic practice with particular attention to the relationship between diagnostic test use and antibiotic treatment. RESULTS Results revealed a range of factors that influence veterinary diagnostic practice and demonstrate the continuing importance of clinical observation and animal/herd knowledge in the selection of antibiotic treatment. CONCLUSION The findings identify a considerable ambivalence on the part of farm animal veterinarians regarding the current and future uses of rapid and point-of-care diagnostic tests as a means of improving clinical diagnosis and addressing inappropriate antibiotic medicine use.
Collapse
Affiliation(s)
- Kin Wing Chan
- College of Life and Environmental Sciences, Department of Geography, University of Exeter, Exeter, Devon, UK
| | - Alison M Bard
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK
| | - Katherine E Adam
- The Innogen Institute, Science Technology and Innovation Studies, Old Surgeons' Hall High School Yards, The University of Edinburgh, Edinburgh, UK
| | - Gwen M Rees
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK
| | - Lisa Morgans
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK.,Innovation for Agriculture, Arthur Rank Centre, Kenilworth, UK
| | - Liz Cresswell
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK
| | - Stephen Hinchliffe
- College of Life and Environmental Sciences, Department of Geography, University of Exeter, Exeter, Devon, UK
| | - David C Barrett
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK
| | - Kristen K Reyher
- Bristol Veterinary School, Dolberry Building Langford, University of Bristol, Bristol, UK
| | - Henry Buller
- College of Life and Environmental Sciences, Department of Geography, University of Exeter, Exeter, Devon, UK
| |
Collapse
|
14
|
Abstract
Mastitis, inflammation of the bovine mammary gland, is generally caused by intramammary infection with bacteria, and antimicrobials have long been a corner stone of mastitis control. As societal concern about antimicrobial use in animal agriculture grows, there is pressure to reduce antimicrobial use in dairy farming. Point-of-care tests for on-farm use are increasingly available as tools to support this. In this Research Reflection, we consider available culture-dependent and culture-independent tests in the context of ASSURED criteria for low-resource settings, including convenience criteria, scientific criteria and societal criteria that can be used to evaluate test performance. As tests become more sophisticated and sensitive, we may be generating more data than we need. Special attention is given to the relationship between test outcomes and treatment decisions, including issues of diagnostic refinement, antimicrobial susceptibility testing, and detection of viable organisms. In addition, we explore the role of technology, big data and people in improved performance and uptake of point-of-care tests, recognising that societal barriers may limit uptake of available or future tests. Finally, we propose that the 3Rs of reduction, refinement and replacement, which have been used in an animal welfare context for many years, could be applied to antimicrobial use for mastitis control on dairy farms.
Collapse
|
15
|
Griffioen K, Cornelissen J, Heuvelink A, Adusei D, Mevius D, Jan van der Wal F. Development and evaluation of 4 loop-mediated isothermal amplification assays to detect mastitis-causing bacteria in bovine milk samples. J Dairy Sci 2020; 103:8407-8420. [PMID: 32564949 DOI: 10.3168/jds.2019-18035] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Accepted: 04/06/2020] [Indexed: 12/22/2022]
Abstract
Farmers prefer fast, sensitive, and on-site tests for treatment decisions on mastitis. Due to the time to results of the currently available diagnostic tools, these are rarely used for that purpose. Genotypic tests that do not require a growth step may be suitable for on-site testing, for example loop-mediated isothermal amplification (LAMP), which has been described as a sensitive test that can be used on-site. Therefore, this study aimed to develop and evaluate LAMP assays for the detection of a subset of mastitis-causing pathogens, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus spp., in milk from cows with clinical mastitis. Furthermore, a generic nucleic acid lateral flow immunoassay (NALFIA) was evaluated as a potential on-site readout of the LAMP assays. For each assay of LAMP and NALFIA, the limit of detection and analytical specificity were determined using isolates, and the diagnostic specificity was determined using selected samples with known etiology. In addition, the diagnostic specificity of LAMP was determined using field samples with unknown etiology at testing. Bacteriological culture with identification by mass spectrometry was used as a reference method. The 4 assays had a kappa ≥0.73 with the reference method when testing the selected samples, but ≥0.47 when testing field samples. After correcting for prevalence, kappa was ≥0.80 for the E. coli, K. pneumoniae, and Staph. aureus assays. The Streptococcus spp. assay had a kappa of 0.47 (0.48 after correction) with the reference method, probably caused by the assay broadly targeting a genus instead of a particular species. The NALFIA readout was found to have kappa ≥0.81 for the E. coli, Staph. aureus, and Streptococcus spp. assays at a generic runtime, but for the K. pneumoniae assay a shorter runtime could be used. In conclusion, LAMP is a promising method for fast on-site tests for mastitis-causing pathogens if the current elaborate method for sample preparation is replaced by a simplified protocol. The NALFIA is an easy and reliable readout for on-site use, with the observation that for the current assay designs a generic runtime is not yet possible for the chosen set of pathogens. If associated with a simple and fast sample preparation protocol, the combination of LAMP and NALFIA has the potential to enable fast and reliable on-site testing of clinical mastitis milk samples.
Collapse
Affiliation(s)
- Karien Griffioen
- Faculty of Veterinary Medicine, Department of Farm Animal Health, Utrecht University, PO Box 80151, 3508 TD Utrecht, the Netherlands.
| | - Jan Cornelissen
- Wageningen Bioveterinary Research, Department of Infection Biology, Wageningen UR, PO Box 65, 8200 AB Lelystad, the Netherlands
| | | | - Daniela Adusei
- Wageningen Bioveterinary Research, Department of Infection Biology, Wageningen UR, PO Box 65, 8200 AB Lelystad, the Netherlands
| | - Dik Mevius
- Wageningen Bioveterinary Research, Department of Infection Biology, Wageningen UR, PO Box 65, 8200 AB Lelystad, the Netherlands; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, PO Box 80165, 3508 TD Utrecht, the Netherlands
| | - Fimme Jan van der Wal
- Wageningen Bioveterinary Research, Department of Infection Biology, Wageningen UR, PO Box 65, 8200 AB Lelystad, the Netherlands
| | | |
Collapse
|
16
|
Schwendner AA, Lam TJGM, Bodmer M, Cousin ME, Schüpbach-Regula G, van den Borne BHP. Knowledge, attitude and practices of Swiss dairy farmers towards intramammary antimicrobial use and antimicrobial resistance: A latent class analysis. Prev Vet Med 2020; 179:105023. [PMID: 32446003 DOI: 10.1016/j.prevetmed.2020.105023] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 03/20/2020] [Accepted: 04/25/2020] [Indexed: 11/16/2022]
Abstract
Understanding farmers' mindsets is important to improve antimicrobial stewardship in the dairy industry. This cross-sectional study aimed to determine farmers' knowledge, attitude, and practices with respect to lactational intramammary antimicrobial use (AMU) and antimicrobial resistance (AMR) in Swiss dairy herds. Based on their approach towards subclinical mastitis (SCM) and non-severe cases of clinical mastitis (CM), subgroups of farmers were identified and compared regarding their knowledge, attitude and practices towards AMU and AMR. After conducting qualitative interviews to develop a questionnaire, an online survey was sent to 1296 randomly selected Swiss dairy farmers. Information was gathered on demographic data and farmers' knowledge, attitude, and practices towards AMU and AMR. A latent class analysis was performed to identify subgroups of farmers based on management of SCM and non-severe CM cases. Based on the results of 542 completed questionnaires, poor knowledge with respect to AMU and AMR was identified, as well as discrepancies between farmers' perceptions and their actual practices. Farmers approached cows with SCM and non-severe CM similarly, indicating they perceived both mastitis states as the same disease. Intramammary antimicrobial products containing cefquinome, which is a highest priority critically important antimicrobial, were among the 3 most commonly applied intramammary antimicrobials. Five latent classes of farmers were identified based on their management towards SCM and non-severe CM. One group of farmers (18.5% of respondents) indicated that they did not treat those mastitis cases, one group only treated SCM cases (13.8% of respondents), one group only treated non-severe CM cases (28.6% of respondents) and the largest group treated both mastitis states (39.1% of respondents). The latter group was subdivided into a latent class of farmers following guidelines for AMU/AMR (25.5% of respondents) and a group of farmers that were not strictly following these guidelines (13.7% of respondents). Regional differences between farmers, according to altitude and language region, explained some of the variation in latent class membership. Latent class membership was associated with farmers' attitude to use antimicrobials as little as possible and with using antimicrobials only after performing bacteriological and susceptibility testing. This study gave detailed insight into Swiss farmers' knowledge, attitude, and practices regarding AMU and AMR and provides opportunities to improve antimicrobial stewardship in Swiss dairy herds. The identified groups of farmers, based on their management practices regarding SCM and non-severe CM, may help to design tailored intervention strategies for improving prudent AMU in the heterogeneous population of dairy farmers in Switzerland.
Collapse
Affiliation(s)
- Anna-Alita Schwendner
- Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Liebefeld, Switzerland
| | - Theo J G M Lam
- GD Animal Health, Deventer, the Netherlands; Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
| | - Michèle Bodmer
- Clinic for Ruminants, Vetsuisse Faculty, University of Bern, Bern, Switzerland
| | - Marie-Eve Cousin
- Consumer Behavior, Institute for Environmental Decisions (IED), ETH Zürich, Zürich, Switzerland
| | | | - Bart H P van den Borne
- Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Liebefeld, Switzerland; Business Economics Group, Wageningen University, Wageningen, the Netherlands.
| |
Collapse
|
17
|
The informative value of an overview on antibiotic consumption, treatment efficacy and cost of clinical mastitis at farm level. Prev Vet Med 2019; 165:63-70. [PMID: 30851929 DOI: 10.1016/j.prevetmed.2019.02.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Revised: 02/02/2019] [Accepted: 02/04/2019] [Indexed: 11/20/2022]
Abstract
This paper addresses whether it is worthwhile investing time in a more comprehensive documentation and analysis of farm specific data for mastitis treatment. Whilst most farmers keep some records, many refrain from investing more effort in making them more detailed. Therefore, information on farm-specific antibiotic consumption, effectiveness of treatments and the costs of mastitis are lacking; as well as the ability to identify and realise possibilities for improvement. An observational study was conducted on 30 dairy farms, to obtain an overview of farming practice, recording detailed data (using herd management software) on: milk records, diagnostics, preventive and therapeutic treatments and cost of mastitis, on an individual cow level. Out of a total of 30,633 cows, 67% received medication for the treatment or prevention of mastitis over a year. Antibiotics were chosen for 96% of udder treatments; including those for dry cows. Over 32% of the antibiotics used during lactation belonged to the 'highest priority critically important antimicrobial' category. Success of therapeutic treatment (assessed by individual somatic cell count (SCC)) ranged from 18% to 59% and total costs of mastitis per cow and year from € 158 to € 483. The high variations in antibiotic consumption, treatment outcomes and cost of mastitis between farms, showed that average or incomplete figures risk giving the wrong impression of a farm. It is thus worthwhile to invest in documentation and analysis of data, so that it is clear where action is required and which investments can be expected to be financially feasible. Benefits emerge from knowledge of antibiotic consumption allowing monitoring and reduction in antibiotic use (as demanded by consumers and legislation), improvements in animal health and welfare thanks to regular checks of how effective a treatment is, and economic benefits due to knowledge of the costs caused by mastitis.
Collapse
|
18
|
Agreement between four commercial diagnostic tests and routine bacteriological culture of milk to determine the udder infection status of dairy cows. Prev Vet Med 2018; 157:162-173. [DOI: 10.1016/j.prevetmed.2018.07.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2017] [Revised: 05/25/2018] [Accepted: 07/03/2018] [Indexed: 01/08/2023]
|
19
|
Heikkilä AM, Liski E, Pyörälä S, Taponen S. Pathogen-specific production losses in bovine mastitis. J Dairy Sci 2018; 101:9493-9504. [PMID: 30122416 DOI: 10.3168/jds.2018-14824] [Citation(s) in RCA: 123] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Accepted: 06/16/2018] [Indexed: 01/18/2023]
Abstract
Reduction in long-term milk yields represents a notable share of the economic losses caused by bovine mastitis. Efficient, economic, and safe measures to prevent these losses require knowledge of the causal agent of the disease. The aim of this study was to investigate pathogen-specific impacts of mastitis on milk production of dairy cows. The materials consisted of milk and health recording data and microbiological diagnoses of mastitic quarter milk samples of 20,234 Finnish dairy cows during 2010, 2011, and 2012. The 6 most common udder pathogens were included in the study: Staphylococcus aureus, non-aureus staphylococci (NAS), Escherichia coli, Corynebacterium bovis, Streptococcus uberis, and Streptococcus dysgalactiae. We used a 2-level multilevel model to estimate curves for lactations with and without mastitis. The data on lactation periods to be compared were collected from the same cow. To enable comparison among lactations representing diverse parities, the estimated lactation curves were adjusted to describe the cow's third lactation. Mastitis caused by each pathogen resulted in milk production loss. The extent of the reduction depended on the pathogen, the timing of mastitis during lactation, and the type of mastitis (clinical vs. subclinical). The 2 most commonly detected pathogens were NAS and Staph. aureus. Escherichia coli clinical mastitis diagnosed before peak lactation caused the largest loss, 10.6% of the 305-d milk yield (3.5 kg/d). The corresponding loss for Staph. aureus mastitis was 7.1% (2.3 kg/d). In Staph. aureus mastitis diagnosed between 54 and 120 d in milk, the loss was 4.3% (1.4 kg/d). The loss was almost equal in both clinical and subclinical mastitis caused by Staph. aureus. Mastitis caused by Strep. uberis and Strep. dysgalactiae resulted in losses ranging from 3.7% (1.2 kg/d) to 6.6% (2.1 kg/d) depending on type and timing of mastitis. Clinical mastitis caused by the minor pathogens C. bovis and NAS also had a negative effect on milk production: 7.4% (2.4 kg/d) in C. bovis and 5.7% (1.8 kg/d) in NAS when both were diagnosed before peak lactation. In conclusion, minor pathogens should not be underestimated as a cause of milk yield reduction. On single dairy farms, control of E. coli mastitis would bring about a significant increase in milk production. Reducing Staph. aureus mastitis is the greatest challenge for the Finnish dairy sector.
Collapse
Affiliation(s)
- A-M Heikkilä
- Natural Resources Institute Finland, Helsinki, Finland FI-00790.
| | - E Liski
- Natural Resources Institute Finland, Helsinki, Finland FI-00790
| | - S Pyörälä
- Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland FI-00014
| | - S Taponen
- Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland FI-00014
| |
Collapse
|
20
|
Klaas IC, Zadoks RN. An update on environmental mastitis: Challenging perceptions. Transbound Emerg Dis 2017; 65 Suppl 1:166-185. [PMID: 29083115 DOI: 10.1111/tbed.12704] [Citation(s) in RCA: 133] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Indexed: 12/15/2022]
Abstract
Environmental mastitis is the most common and costly form of mastitis in modern dairy herds where contagious transmission of intramammary pathogens is controlled through implementation of standard mastitis prevention programmes. Environmental mastitis can be caused by a wide range of bacterial species, and binary classification of species as contagious or environmental is misleading, particularly for Staphylococcus aureus, Streptococcus uberis and other streptococcal species, including Streptococcus agalactiae. Bovine faeces, the indoor environment and used pasture are major sources of mastitis pathogens, including Escherichia coli and S. uberis. A faeco-oral transmission cycle may perpetuate and amplify the presence of such pathogens, including Klebsiella pneumoniae and S. agalactiae. Because of societal pressure to reduce reliance on antimicrobials as tools for mastitis control, management of environmental mastitis will increasingly need to be based on prevention. This requires a reduction in environmental exposure through bedding, pasture and pre-milking management and enhancement of the host response to bacterial challenge. Efficacious vaccines are available to reduce the impact of coliform mastitis, but vaccine development for gram-positive mastitis has not progressed beyond the "promising" stage for decades. Improved diagnostic tools to identify causative agents and transmission patterns may contribute to targeted use of antimicrobials and intervention measures. The most important tool for improved uptake of known mastitis prevention measures is communication. Development of better technical or biological tools for management of environmental mastitis must be accompanied by development of appropriate incentives and communication strategies for farmers and veterinarians, who may be confronted with government-mandated antimicrobial use targets if voluntary reduction is not implemented.
Collapse
Affiliation(s)
- I C Klaas
- Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark
| | - R N Zadoks
- Moredun Research Institute, Penicuik, UK.,Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
| |
Collapse
|
21
|
Vakkamäki J, Taponen S, Heikkilä AM, Pyörälä S. Bacteriological etiology and treatment of mastitis in Finnish dairy herds. Acta Vet Scand 2017; 59:33. [PMID: 28545485 PMCID: PMC5445452 DOI: 10.1186/s13028-017-0301-4] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2016] [Accepted: 05/15/2017] [Indexed: 11/10/2022] Open
Abstract
Background The Finnish dairy herd recording system maintains production and health records of cows and herds. Veterinarians and farmers register veterinary treatments in the system. Milk samples for microbiological analysis are routinely taken from mastitic cows. The laboratory of the largest dairy company in Finland, Valio Ltd., analyzes most samples using real-time PCR. This study addressed pathogen-specific microbiological data and treatment and culling records, in combination with cow and herd characteristics, from the Finnish dairy herd recording system during 2010–2012. Results The data derived from 240,067 quarter milk samples from 93,529 dairy cows with mastitis; 238,235 cows from the same herds served as the control group. No target pathogen DNA was detected in 12% of the samples. In 49% of the positive samples, only one target species and in 19%, two species with one dominant species were present. The most common species in the samples with a single species only were coagulase-negative staphylococci (CNS) (43%), followed by Staphylococcus aureus (21%), Streptococcus uberis (9%), Streptococcus dysgalactiae (8%), Corynebacterium bovis (7%), and Escherichia coli (5%). On average, 36% of the study cows and 6% of the control cows had recorded mastitis treatments during lactation. The corresponding proportions were 16 and 6% at drying-off. For more than 75% of the treatments during lactation, diagnosis was acute clinical mastitis. In the milk samples from cows with a recorded mastitis treatment during lactation, CNS and S. aureus were most common, followed by streptococci. Altogether, 48% of the cows were culled during the study. Mastitis was reported as the most common reason to cull; 49% of study cows and 18% of control cows were culled because of mastitis. Culling was most likely if S. aureus was detected in the milk sample submitted during the culling year. Conclusions The PCR test has proven to be an applicable method also for large-scale use in bacterial diagnostics. In the present study, microbiological diagnosis was unequivocal in the great majority of samples where a single species or two species with one dominating were detected. Coagulase-negative staphylococci and S. aureus were the most common species. S. aureus was also the most common pathogen among the culled cows, which emphasizes the importance of preventive measures.
Collapse
|